We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

DIASORIN

DiaSorin develops, produces and commercializes diagnostic tests for a wide range of clinical areas. The company’s tes... read more Featured Products: More products

Download Mobile App




Monitoring Calcitriol May Help Prevent Chronic Heart Failure Death

By LabMedica International staff writers
Posted on 30 Mar 2015
Print article
The LIAISON XL Analyzer used for the DiaSorin LIAISON XL 1,25 Dihydroxyvitamin D  in vitro chemiluminescent immunoassay
The LIAISON XL Analyzer used for the DiaSorin LIAISON XL 1,25 Dihydroxyvitamin D in vitro chemiluminescent immunoassay (Photo courtesy of DIASORIN)
In patients with chronic heart failure, the vitamin D metabolite 1,25-dihydroxyvitamin D (1,25(OH)2D), also called calcitriol, and its ratio to parathyroid hormone (PTH 1-84) may help predict cardiovascular death.

Heart failure, with high morbidity and mortality, is increasingly prevalent worldwide, and biomarkers may help doctors predict heart failure and help patients survive and patients with decreased calcitriol and decreased ratio of calcitriol to PTH might benefit from more aggressive supplementation.

Scientists at the Cliniques Universitaires Saint Luc (Brussels, Belgium) investigated 170 chronic heart failure patients. Overall, 36 patients were female, 134 patients were male, and the average age was 67 years. Their overall mean ejection fraction was 23%, and the origin of heart failure was ischemic in 119 patients and dilated cardiomyopathy in 51 patients. The team examined the ability of calcitriol and its ratio with PTH(1-84) to predict cardiovascular death in chronic heart failure, and determined the patients' calcitriol and PTH(1-84) levels at baseline. The 1,25(OH)2D was measured by a fully automated LIAISON XL 1,25 Dihydroxyvitamin D assay (DiaSorin; Saluggia, Italy).

The investigators found that serum calcitriol levels decreased markedly according to heart failure severity, and that decreased ratios of calcitriol to PTH(1-84) were significantly related to heart failure severity. After eight years of follow-up, the calcitriol and the ratio of calcitriol to PTH(1-84) were strongly able to predict the deaths of 106 patients who died from cardiovascular causes. In patients with heart failure, vitamin D deficiency and hyperparathyroidism are common, and evidence is growing for the role of vitamin D and PTH in worsening heart failure.

Damien Gruson, PhD, professor and associated laboratory director in the Department of Laboratory Medicine and lead study author, said, “We were surprised by the strong predictive power of 1,25(OH)2D and its ratio to 1-84 PTH. It is noteworthy that in this study the 1,25(OH)2D was measured by a novel extraction-free, fully automated assay based on an unique murine monoclonal antibody, which recognizes the conformational change induced by the binding of the 1,25(OH)2D to a recombinant fusion protein. Our results can provide physicians with a new tool - the 1,25(OH)2D to PTH ratio - to risk stratify heart failure patients.” The study was presented at the annual meeting of the Endocrine Society, ENDO 2015 held March 5-8, 2015, in San Diego (CA, USA).

Related Links:
Cliniques Universitaires Saint Luc
DiaSorin 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.